Cargando…

OTEH-2. High-dimensional analysis of spatial immune cell heterogeneity in glioblastoma reveals differences between contrast-enhancing and non-contrast-enhancing tumor rims

BACKGROUND: Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. GBM remains an incurable disease, with a median survival ~20 months. Complex intercellular interactions within the tumor microenvironment and spatial heterogeneity have challenged and impeded therapeutic effic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watson, Dionysios C, Bayik, Defne, Grabowski, Matthew, Ahluwalia, Manmeet, Mohammadi, Alireza, Lathia, Justin D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264919/ http://dx.doi.org/10.1093/noajnl/vdab070.041

Ejemplares similares

Spatial immunosampling of MRI-defined glioblastoma regions reveals immunologic fingerprint of non-contrast enhancing, infiltrative tumor margins
por: Grabowski, Matthew M., et al.
Publicado: (2023)

OTEH-7. Molecular characterization of tumor stiffness in glioblastoma
por: Halldorsson, Skarphedinn, et al.
Publicado: (2021)

Release the ballast: Glioblastoma rises above radiation therapy by exporting miR-603 in extracellular vesicles to become treatment-resistant
por: Bayik, Defne, et al.
Publicado: (2020)

OTEH-4. Deeper insight into intratumoral heterogeneity by MRI and PET-guided stereotactic biopsies from glioblastoma patients
por: Anand, Atul, et al.
Publicado: (2021)

OTEH-11. Single Cell RNA Sequencing to identify cellular heterogeneity with in Pituitary Adenomas
por: Jain, Saket, et al.
Publicado: (2021)

OTEH-10. Evolutionary trajectory of epigenomic of gliomas
por: Malta, Tathiane, et al.
Publicado: (2021)

OTEH-1. Alternative RNA splicing modulates composition of ribosomes and determines spatial phenotype of glioblastoma cells
por: Pavlyukov, Marat, et al.
Publicado: (2021)

OTEH-8. Pathway-based approach reveals sensitivity to radiation when targeting E2F1 in Glioblastoma
por: Alvarado, Alvaro, et al.
Publicado: (2021)

OTEH-12. Assessing Adaptive Responses to Loss of Extrachromosomal DNA Amplification
por: Berezovsky, Artem, et al.
Publicado: (2021)

OTEH-5. Characterization of long-non coding RNA associated ceRNA network hub gene involved in glioblastoma multiforme lipid metabolism
por: Rizalhanafi, Fatin Nabihah, et al.
Publicado: (2021)

The missing link? LGMN connects hypoxia and immunosuppression in glioblastoma
por: Mitchell, Jonathan, et al.
Publicado: (2023)

OTEH-3. Targeted Gene-Expression analysis during malignant transformation in primary and secondary malignant meningioma
por: Maier, Andrea Daniela, et al.
Publicado: (2021)

NI-14 estimation of property of MRI non-contrast enhanced lesion of Glioblastoma using T1/T2 ratio
por: Yamamoto, Shota, et al.
Publicado: (2021)

OTEH-6. Algorithmic approach to characterize post-treatment recurrent glioma using RNA sequencing and quantitative histopathology
por: Argenziano, Michael, et al.
Publicado: (2021)

SerpinB3 drives cancer stem cell survival in glioblastoma
por: Lauko, Adam, et al.
Publicado: (2022)

Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets
por: Bayik, Defne, et al.
Publicado: (2022)

Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma
por: Lee, Juyeun, et al.
Publicado: (2023)

MRI predictors for the conversion from contrast-enhancing to iron rim multiple sclerosis lesions
por: Wenzel, Nicolas, et al.
Publicado: (2022)

Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression
por: Alban, Tyler J., et al.
Publicado: (2020)

IL-11 drives postsurgical hepatocellular carcinoma recurrence
por: Lauko, Adam, et al.
Publicado: (2019)

Contrast-Enhanced Cone-Beam Breast CT: An Analysis of Diagnostic Value in Predicting Breast Lesion With Rim Enhancement Malignancy
por: Zhao, Xin, et al.
Publicado: (2022)

OTEH-9. scRNA sequencing of proneural GBM avatar model reveals acquisition of oncogenic transcriptional programming and infers a developmental path towards a genomically unstable state
por: Taylor, Brett M, et al.
Publicado: (2021)

Preoperative differentiation of hepatocellular carcinoma with peripheral rim-like enhancement from intrahepatic mass-forming cholangiocarcinoma on contrast-enhanced MRI
por: Zhang, Sisi, et al.
Publicado: (2022)

CLRM-01. MACHINE LEARNING TO UNCOVER SIGNATURES OF VULNERABILITY IN GLIOBLASTOMA UMBRELLA SIGNATURE TRIAL (GUST)
por: Peng, Sen, et al.
Publicado: (2021)

Multimodal MRI characteristics of the glioblastoma infiltration beyond contrast enhancement
por: Yan, Jiun-Lin, et al.
Publicado: (2019)

EGFR Pathway Expression Persists in Recurrent Glioblastoma Independent of Amplification Status
por: Dhawan, Andrew, et al.
Publicado: (2023)

Contrast enhancement efficacy of iodinated contrast media: Effect of molecular structure on contrast enhancement
por: Imai, Kuniharu, et al.
Publicado: (2018)

IMG-15. PEDIATRIC GLIOBLASTOMAS CONTRAST ENHANCEMENT PATTERN IS PREDICTIVE OF SURVIVAL
por: Sadighi, Zsila, et al.
Publicado: (2020)

Alterations in EGFR and PDGFRA are associated with the localization of contrast-enhancing lesions in glioblastoma
por: Makino, Ryutaro, et al.
Publicado: (2023)

Simultaneous Visualization of Vessels and Brain Tumor with Contrast-enhanced Three-dimensional Phase-contrast MR Imaging
por: Shigenaga, Yutaka, et al.
Publicado: (2017)

CLRM-10 METIS (EF-25): A PIVOTAL, RANDOMIZED CONTROLLED STUDY OF TUMOR TREATING FIELDS IN PATIENTS WITH 1–10 BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
por: Mehta, Minesh, et al.
Publicado: (2022)

Contrast-Enhanced Ultrasound
por: Xu, Hui-Xiong, et al.
Publicado: (2015)

30. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
por: Mehta, Minesh P, et al.
Publicado: (2020)

Glioblastoma Presenting with Steroid-Induced Pseudoregression of Contrast Enhancement on Magnetic Resonance Imaging
por: Mazur, Marcus D., et al.
Publicado: (2012)

Correlation between contrast enhancement on intraoperative magnetic resonance imaging and histopathology in glioblastoma
por: Kubben, Pieter L., et al.
Publicado: (2012)

Prediction of Prognosis in Glioblastoma Using Radiomics Features of Dynamic Contrast-Enhanced MRI
por: Pak, Elena, et al.
Publicado: (2021)

Repeatability of tumor perfusion kinetics from dynamic contrast-enhanced MRI in glioblastoma
por: Woodall, Ryan T, et al.
Publicado: (2021)

Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Pharmacokinetic Variables in Glioblastoma Patients: Analysis of Contrast-Enhancing Lesions and Non-Enhancing T2 High-Signal Intensity Lesions
por: Kang, Yeonah, et al.
Publicado: (2020)

Feasibility of non-contrast-enhanced four dimensional (4D) MRA in head and neck tumors, comparison with contrast-enhanced 4D MRA
por: Sakai, Mio, et al.
Publicado: (2016)

Three-dimensional Contrast-enhanced Ultrasound in Response Assessment for Breast Cancer: A Comparison with Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathology
por: Jia, Wan-Ru, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hce2f2pfjmb04e56o24rbn7jiv